• Describe the typical and atypical clinical features of neuralgic amyotrophy.

  • Explain the underlying pathophysiologic mechanisms, including immune, mechanical, and genetic factors.

  • Interpret diagnostic findings from EMG, nerve ultrasound, and MRI relevant to NA.

  • Apply evidence-based treatment strategies, including the role of early corticosteroid therapy.

Session date: 
05/12/2025 - 4:00pm to 5:00pm CDT
Location: 
Virtually
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Please login or register to take this course.
Discloser List CME Internal Report